Immunogenicity and safety of Vero cell culture-derived Japanese encephalitis vaccine: a phase 3 study in Chinese infants
Background Japanese encephalitis (JE) is a severe infectious disease of the central nervous system. Vaccination with Vero cell culture-derived vaccines may effectively reduce JE incidence.Research Design and Methods In this single-center, randomized, blinded, positive-controlled clinical trial in Ch...
Saved in:
Main Authors: | Huanhuan Wang (Author), Juan Wang (Author), Shijie Yan (Author), Gengfan Zhao (Author), Shanzhen Wang (Author), Hong Tao (Author), Ye Xu (Author), Jinfeng Wu (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
by: Pornthep Chanthavanich, et al.
Published: (2018) -
Safety profile comparison of chimeric live attenuated and Vero cell-derived inactivated Japanese encephalitis vaccines through an active surveillance system in Australia
by: Nazmul Islam, et al.
Published: (2022) -
Evervac: phase I/II study of immunogenicity and safety of a new adjuvant-free TBE vaccine cultivated in Vero cell culture
by: Mikhail F. Vorovitch, et al.
Published: (2020) -
Antibody persistence upto 5 years after primary immunization and booster with an inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
by: Weerawan Hattasingh, et al.
Published: (2022) -
Safety of Japanese encephalitis vaccines
by: Ya-Li Hu, et al.
Published: (2021)